Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 3/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | PLAU | P00749 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | CCR5 | P51681 | 1/20 | 0.48 |
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921855 | 0.85 | MAOA (0.65) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL275526 | 0.82 | MAOA (0.77) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL29785641 | 0.82 | MAOA (0.77) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL2470956 | 0.82 | MAOA (0.77) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL2874213 | 0.81 | ALDH1A1 (0.48) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL337735 | 0.80 | — | — | |
| SCHEMBL2557888 | 0.80 | MAOA (0.74) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL3194915 | 0.80 | — | — | |
| Benzene SCHEMBL10803509 | 0.80 | MAOA (0.82) | ADRA2AADRA2BADRA2CMAOAMAOB | |
| SCHEMBL8136475 | 0.79 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773347-A | Benzimidazole compound based on ortho-substitution and application thereof | 宁波卢米蓝新材料有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114736208-A | Benzimidazole compound based on multi-donor substitution and application thereof | 宁波卢米蓝新材料有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114507219-A | Organic compound based on naphthalimide and application thereof | 宁波卢米蓝新材料有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-113666918-A | Organic electroluminescent compound with high thermal stability and organic electroluminescent device | 南京高光半导体材料有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-113493446-A | Carbazolyl-based organic electroluminescent compound and organic electroluminescent device | 南京高光半导体材料有限公司 | 2021-10-12 | — | — | CN | claimed |
| CN-113024497-A | Organic electroluminescent compound and organic electroluminescent device containing same | 南京高光半导体材料有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-6235730-B1 | ANTICHOLESTEROL AGENT, ANTILIPEMIC AGENT | JAPAN TOBACCO, INC. (JP) | 2001-05-22 | — | — | US | claimed |
| EP-0970954-A1 | 3-PIPERIDYL-4-OXOQUINAZOLINE DERIVATIVES AND MEDICINCAL COMPOSITIONS CONTAINING THE SAME | JAPAN TOBACCO INC. (JP) | 2000-01-12 | — | — | EP | claimed |
| EP-0412699-B1 | Nitrosothiol derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1994-04-27 | — | — | EP | claimed |
| EP-0412699-A2 | Nitrosothiol derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-02-13 | — | — | EP | claimed |
| US-11980092-B2 | Organic electroluminescence element | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-05-07 | — | — | US | disclosed |
| US-11944004-B2 | Organic electroluminescence element | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-03-26 | — | — | US | disclosed |
| US-11925107-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-03-05 | — | — | US | disclosed |
| US-11925114-B2 | Indenocarbazole compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-03-05 | — | — | US | disclosed |
| US-20240032321-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-0475264-A1 | Electrophotographic photoreceptor | Mitsubishi Chemical Corporation (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-5080991-A | ELECTROPHOTOGRAPHIC PHOTORECEPTOR WITH A HYDRAZONE | MITSUBISHI KASEI CORPORATION (JP) | 1992-01-14 | — | — | US | disclosed |
| EP-0435165-A1 | Electrophotographic plate | Mitsubishi Chemical Corporation (JP) | 1991-07-03 | — | — | EP | disclosed |
| EP-0414185-A2 | Electrophotographic photoreceptor | Mitsubishi Chemical Corporation (JP) | 1991-02-27 | — | — | EP | disclosed |
| EP-0273426-A2 | Enamine derivatives, production thereof and electrophotographic plates containing the same | Hitachi Chemical Co., Ltd. (JP) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11925107-B2 | Organic electroluminescent device | LEF1, KCNN2, AXIN2 | ADRA2A 596/4885ADRA2B 783/4885ADRA2C 1444/4885 |
| US-11925114-B2 | Indenocarbazole compound and organic electroluminescence device | OXA1L, KCNJ1, ABCB1 | ADRA2A 2992/4885ADRA2B 731/4885ADRA2C 2296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.